top of page
Business Conference

Gazette News

News, insights and highlights

Highlights 

Our events and highlights

๐—˜๐˜…๐—ฝ๐—ฎ๐—ป๐—ฑ๐—ถ๐—ป๐—ด ๐—•๐—ผ๐—ฟ๐—ฑ๐—ฒ๐—ฟ๐˜€, ๐—ฆ๐—ต๐—ฎ๐—ฟ๐—ถ๐—ป๐—ด ๐—œ๐—ป๐˜€๐—ถ๐—ด๐—ต๐˜๐˜€

14 May 2025

A heartfelt thank you to the organizers for inviting ARQon Group, represented by Kai Li Saw, as a guest speaker at the event. We were proud to showcase our portfolio and share key insights on ASEAN registration processes and market entry strategies with a highly engaged audience of local and Chinese investors and entrepreneurs.

The event served as an important platform to:
๐Ÿ”น Address core challenges in market expansion, such as compliance access, regulatory strategies, and tariff barriers
๐Ÿ”น Interpret the current status and emerging trends in the eye health market
๐Ÿ”น Build a space for practical experience sharing and exploring potential cross-border cooperation
๐Ÿ”น Offer policy guidance for Chinese MedTech companies with overseas ambitions

The Q&A and networking sessions were especially valuable, allowing us to exchange knowledge, explore partnerships, and gain a deeper understanding of market needs from every aspect of the industry.

We were grateful for the opportunity to participate in this meaningful event and so proud to be able to support the MedTech ecosystem by building bridges across Southeast Asia.
Let's keep the momentum going!

๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐— ๐—ฒ๐—ฒ๐˜๐˜€ ๐—œ๐—บ๐—ฝ๐—ฎ๐—ฐ๐˜ ๐—ฎ๐˜ ๐—š๐—œ๐—ง๐—˜๐—ซ ๐—”๐˜€๐—ถ๐—ฎ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ

23 Apr 2025

After two intense days filled with deep tech dives and non-stop networking, the energy from hashtag#GITEXAsia2025 is still very much alive!

The days were long, but the value was undeniable โ€” from the insights gained to the meaningful connections formed, it was truly an inspiring experience. We had the pleasure of reconnecting with visionary startups and laying the groundwork for exciting opportunities ahead.

The event brought together 500+ startups from across the globe and 250+ global investors, all under one roof, sparking discussions, deal flows, and ideas that could shape the future.

๐Ÿ”น We explored the ๐—ณ๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—ฑ๐—ถ๐—ด๐—ถ๐˜๐—ฎ๐—น ๐—ต๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ through AI diagnostics, telemedicine, and next-gen health monitoring systems.
๐Ÿ”น We gained valuable insights into the growing ๐—ถ๐—บ๐—ฝ๐—ผ๐—ฟ๐˜๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ผ๐—ณ ๐—ฐ๐˜†๐—ฏ๐—ฒ๐—ฟ๐˜€๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ถ๐˜๐˜† in todayโ€™s digital-first world.
๐Ÿ”น And we witnessed firsthand how ๐—”๐—œ and ๐—ฟ๐—ผ๐—ฏ๐—ผ๐˜๐—ถ๐—ฐ๐˜€ are revolutionizing industries, streamlining operations, and reshaping our day-to-day lives.

GITEX has once again proven itself to be a true catalyst for global tech and startup innovation, now taking center stage in Asia.

The energy, ambition, and collaboration seen throughout the event were nothing short of inspiring.
The future is being built now, and weโ€™re excited to be a part of it.

๐—•๐—ฟ๐—ถ๐—ฑ๐—ด๐—ถ๐—ป๐—ด ๐—ง๐—ฟ๐—ฎ๐—ฑ๐—ถ๐˜๐—ถ๐—ผ๐—ป & ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป

24 Mar 2025

Honored to attend the Taiwan Trade Mission on Traditional Chinese Medicines (TCM) and Herbal Supplements, organized by TAITRA and the International Trade Administration! This event showcased how Taiwan is revolutionizing pharmaceutical and biomedical advancements by integrating traditional wisdom with cutting-edge technology.

Key areas of expertise presented included:
๐Ÿ”ฌ ๐—ฆ๐—ฝ๐—ฒ๐—ฐ๐—ถ๐—ฎ๐—น๐—ถ๐˜‡๐—ฒ๐—ฑ ๐—ฟ๐—ฒ๐˜€๐—ฒ๐—ฎ๐—ฟ๐—ฐ๐—ต & ๐—ฑ๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ for Active Pharmaceutical Ingredients (API)
๐Ÿ’Š ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ ๐—ง๐—–๐—  ๐—ณ๐—ผ๐—ฟ๐—บ๐˜‚๐—น๐—ฎ๐˜๐—ถ๐—ผ๐—ป๐˜€, combining ancient practices with modern science
โš—๏ธ ๐—ข๐—˜๐— /๐—ข๐——๐—  ๐˜€๐—ฒ๐—ฟ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ for tailored healthcare solutions
๐Ÿงช ๐——๐—ฒ๐˜ƒ๐—ฒ๐—น๐—ผ๐—ฝ๐—บ๐—ฒ๐—ป๐˜ ๐—ผ๐—ณ ๐˜€๐˜‚๐—ฏ๐—น๐—ถ๐—ป๐—ด๐˜‚๐—ฎ๐—น ๐—ด๐—ฟ๐—ฎ๐—ป๐˜‚๐—น๐—ฒ๐˜€ (๐—ฝ๐—ฒ๐—น๐—น๐—ฒ๐˜๐˜€) for enhanced bioavailability
๐Ÿฅ ๐—ฆ๐˜๐—ฎ๐˜๐—ฒ-๐—ผ๐—ณ-๐˜๐—ต๐—ฒ-๐—ฎ๐—ฟ๐˜ ๐—ต๐—ผ๐˜€๐—ฝ๐—ถ๐˜๐—ฎ๐—น๐˜€, telemedicine, and robotic surgical systems for the future of healthcare

This mission reinforced the global potential of TCM in the pharmaceutical industry, transforming how we approach holistic and data-driven healthcare solutions. Looking forward to seeing these innovations expand worldwide!

๐—ฆ๐˜๐—ฟ๐—ฒ๐—ป๐—ด๐˜๐—ต๐—ฒ๐—ป๐—ถ๐—ป๐—ด ๐—ค๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† & ๐—–๐—ผ๐—บ๐—ฝ๐—น๐—ถ๐—ฎ๐—ป๐—ฐ๐—ฒ ๐—ถ๐—ป ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ฐ๐—ฎ๐—ฟ๐—ฒ ๐—ฎ๐—ป๐—ฑ ๐— ๐—ฒ๐—ฑ๐—ง๐—ฒ๐—ฐ๐—ต

5 May 2025

It was a privilege to attend this impactful session, designed to elevate the standards of healthcare products and uphold patient safety through robust regulatory frameworks.

ARQon Group was proud to contribute to the discussion, with Dr. Stephen Hsu, Ph.D. presenting on ๐—š๐—ผ๐—ผ๐—ฑ ๐— ๐—ฎ๐—ป๐˜‚๐—ณ๐—ฎ๐—ฐ๐˜๐˜‚๐—ฟ๐—ถ๐—ป๐—ด ๐—ฃ๐—ฟ๐—ฎ๐—ฐ๐˜๐—ถ๐—ฐ๐—ฒ๐˜€ (๐—š๐— ๐—ฃ) ๐—ถ๐—ป ๐—ฝ๐—ต๐—ฎ๐—ฟ๐—บ๐—ฎ๐—ฐ๐—ฒ๐˜‚๐˜๐—ถ๐—ฐ๐—ฎ๐—น ๐—พ๐˜‚๐—ฎ๐—น๐—ถ๐˜๐˜† ๐—ฎ๐˜€๐˜€๐˜‚๐—ฟ๐—ฎ๐—ป๐—ฐ๐—ฒ. As a critical foundation for innovative healthcare and MedTech solutions, the presentation provided a comprehensive overview of:
โœ”๏ธ ๐—™๐˜‚๐—ป๐—ฑ๐—ฎ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—น ๐—š๐— ๐—ฃ ๐—ฝ๐—ฟ๐—ถ๐—ป๐—ฐ๐—ถ๐—ฝ๐—น๐—ฒ๐˜€ that ensure consistency and control in manufacturing processes
โœ”๏ธ ๐—ง๐˜†๐—ฝ๐—ฒ๐˜€ ๐—ผ๐—ณ ๐—ถ๐—ป๐˜€๐—ฝ๐—ฒ๐—ฐ๐˜๐—ถ๐—ผ๐—ป๐˜€ ๐—ฐ๐—ผ๐—ป๐—ฑ๐˜‚๐—ฐ๐˜๐—ฒ๐—ฑ to uphold both local and international quality standards
โœ”๏ธ ๐—ง๐—ต๐—ฒ ๐—ฎ๐—ฝ๐—ฝ๐—น๐—ถ๐—ฐ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ผ๐—ณ ๐—ฟ๐—ถ๐˜€๐—ธ-๐—ฏ๐—ฎ๐˜€๐—ฒ๐—ฑ ๐—ฐ๐—ฎ๐˜๐—ฒ๐—ด๐—ผ๐—ฟ๐—ถ๐˜‡๐—ฎ๐˜๐—ถ๐—ผ๐—ป in identifying and addressing GMP deficiencies

The session as a whole reinforced the importance of risk management and pharmaceutical quality systems in post-market activities. It deepened our understanding of GMP and GSDP in maintaining product quality throughout the lifecycle, while also exploring post-market surveillance and enforcement measures, the structure of pharmacovigilance frameworks, and the role of critical thinking in regulatory decision-making.

Our heartfelt thanks to the organizers for the kind invitation. Every shared perspective plays a part in shaping a stronger, safer, and more compliant healthcare and MedTech ecosystem.

๐—ฆ๐—ต๐—ฎ๐—ฝ๐—ถ๐—ป๐—ด ๐˜๐—ต๐—ฒ ๐—™๐˜‚๐˜๐˜‚๐—ฟ๐—ฒ ๐˜„๐—ถ๐˜๐—ต ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป & ๐—”๐—œ

21 Apr 2025

Thank you to the Association of Small & Medium Enterprises and Amazon Web Services (AWS) Singapore for organizing a thought-provoking and energizing event that brought together innovators, entrepreneurs, and tech enthusiasts under one roof.

One of the event's key highlights was the insightful presentations delivered by distinguished speakers Richard Goh, Valerie Leong, and Jonathan Ong, who provided structured frameworks and practical, real-world strategies for fostering innovation within organizational environments.

๐—ž๐—ฒ๐˜† ๐—ง๐—ฎ๐—ธ๐—ฒ๐—ฎ๐˜„๐—ฎ๐˜†๐˜€ ๐—ง๐—ต๐—ฎ๐˜ ๐—ฅ๐—ฒ๐˜€๐—ผ๐—ป๐—ฎ๐˜๐—ฒ:
๐Ÿ” โ€œWorking Backwardsโ€ Approachโ€”A product development mindset that starts with the customer. Instead of asking, โ€œWhat can we build?โ€ the better question is, โ€œWhat does the customer need?โ€ This approach reframes innovation with clarity and intention, from FAQs to solution prototypes.

๐Ÿ›๏ธ ๐—–๐˜‚๐—น๐˜๐˜‚๐—ฟ๐—ฒ ๐—ผ๐—ณ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ปโ€”Innovation isnโ€™t a one-off effortโ€”itโ€™s a habit, a system. Itโ€™s about removing barriers, empowering small teams, and fostering curiosity at every level of the organization.

๐Ÿค– ๐—›๐—ฎ๐—ป๐—ฑ๐˜€-๐—ผ๐—ป ๐˜„๐—ถ๐˜๐—ต ๐—š๐—ฒ๐—ป-๐—”๐—œ ๐—ง๐—ผ๐—ผ๐—น๐˜€โ€” Exploring Amazonโ€™s Gen-AI capabilities wasnโ€™t just eye-openingโ€”it was empowering. From content generation to ideation support, AI has the potential to transform the way we work and create, especially in resource-strapped environments.

๐Ÿค ๐—ก๐—ฒ๐˜๐˜„๐—ผ๐—ฟ๐—ธ๐—ถ๐—ป๐—ด ๐˜„๐—ถ๐˜๐—ต ๐—ฃ๐˜‚๐—ฟ๐—ฝ๐—ผ๐˜€๐—ฒโ€”The Networking Luncheon was more than just exchanging business cards. It was about connecting with like-minded individuals who share a vision of leveraging technology for meaningful impact.

This event reminded me that innovation is not just about new toolsโ€”itโ€™s about new thinking.
Hereโ€™s to cultivating that mindset and collaborating across industries to build solutions that truly matter. ๐Ÿš€

Harnessing AI and Cloud Platforms for Healthcare Solutions

12 Mar 2025

Exciting times are ahead for healthcare and MedTech! We had an incredible experience attending this seminar, where industry experts, innovators, and startups sat together to explore groundbreaking advancements and the transformative power of cloud technologies in the healthcare landscape.

๐Ÿค Collaborative Innovation: AWS, startups, and clinicians work hand-in-hand to drive AI-powered solutions for better patient care, efficient hospital operations, and predictive healthcare analytics.
๐Ÿ’ก AWS Activate for Startups: This program is a game changer! It offers crucial support for startups in defining target markets, validating product-market fit, and building strong value propositions.
๐Ÿ’ฐ Programs & Funding Opportunities: A wealth of funding resources is available within National Healthcare Group (NHG), NWS, and at the national level to help innovative ideas scale from concept to market.
โš™๏ธ Centre for Medical Technologies & Innovations (CMTi): Driving NHG's vision of "Adding years of healthy life", CMTi focuses on developing solutions that enhance healthcare delivery. The case study highlighted the rising global burden of cardiovascular diseases, emphasizing the urgency of innovation in preventive and therapeutic care
๐Ÿ’ป Centre of AI in Medicine (C-AIM): Pioneering AI-driven advancements, C-AIM is dedicated to multidisciplinary research that ensures AI solutions effectively collaborate with clinicians, patients, and key stakeholders to enhance healthcare outcomes.

With such a dynamic project funding landscape, the future looks bright for MedTech and AI-driven healthcare solutions. These initiatives provide a solid foundation to transform innovative business ideas into market-ready solutions.

๐—œ๐— ๐——๐—ฆ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐—ข๐—ณ๐—ณ๐—ถ๐—ฐ๐—ถ๐—ฎ๐—น๐—น๐˜† ๐—ž๐—ถ๐—ฐ๐—ธ๐˜€ ๐—ข๐—ณ๐—ณ

24 Apr 2025

Weโ€™re pleased to announce the successful launch of IMDS 2025 (IMDS - International Medical Device School), our hybrid learning initiative designed to empower MedTech professionals worldwide.

Thank you to all participants and speaker, Basak Baranoglu Demirci, who joined us for the opening sessions. Your engagement and insights contributed to a dynamic and enriching start.

Key highlights from the sessions included:
โœ… In-depth updates on EU MDR and IVDR
โœ… Practical strategies spanning the entire MedTech product lifecycle
โœ… Expert-led discussions on regulatory, quality, and commercialization pathways

This yearโ€™s program consists of 10 curated sessions, available both virtually and on-site, tailored to meet the needs of professionals navigating the evolving medical device regulatory landscape.

๐ŸŽ“ Participants who complete the full series will be awarded the IMDS 2025 Certificate of Completion.

๐Ÿ”— Registration link: https://lnkd.in/gP7FiQUB

We look forward to your continued participation and invite you to follow us for upcoming sessions and industry insights.

๐—˜๐˜…๐—ฝ๐—น๐—ผ๐—ฟ๐—ถ๐—ป๐—ด ๐—จ๐—ž-๐—ฆ๐—ถ๐—ป๐—ด๐—ฎ๐—ฝ๐—ผ๐—ฟ๐—ฒ ๐—ฃ๐—ฎ๐—ฟ๐˜๐—ป๐—ฒ๐—ฟ๐˜€๐—ต๐—ถ๐—ฝ๐˜€ ๐˜„๐—ถ๐˜๐—ต ๐˜๐—ต๐—ฒ ๐—˜๐—ฆ๐—ฆ ๐—ง๐—ฒ๐—ฎ๐—บ

2 Apr 2025

Thank you to the British High Commission Singapore (UK in Singapore) for the kind invitation to the high tea networking session with the Export Support Service (ESS) team. It was a great opportunity to connect with industry peers and market advisors and explore new opportunities between the UK and Singapore.

This session marks a significant step in expanding our business journey into the UK market and building bridges with UK-based entrepreneurs. We look forward to potential partnerships and future collaborations across borders.

๐——๐—ฟ๐—ถ๐˜ƒ๐—ถ๐—ป๐—ด ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ง๐—ฒ๐—ฐ๐—ต ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป

21 Feb 2025

ARQon had an insightful experience where industry experts, Kian Ann Ang, Gordon Xiong, Ph.D., May Lee, Vicky Tang, and YW Devan Tay, shared their knowledge on key initiatives shaping the future of healthcare innovation. Warm gratitude to all speakers for their valuable insights!

Highlights from the session:
- ๐—œ๐—ป๐˜๐—ฟ๐—ผ๐—ฑ๐˜‚๐—ฐ๐˜๐—ถ๐—ผ๐—ป ๐˜๐—ผ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ซ
Learning about HealthX, which provides advisory services and access to enablers to help innovators scale their solutions effectively.
- ๐—˜๐˜…๐—ฐ๐—ถ๐˜๐—ถ๐—ป๐—ด ๐˜‚๐—ฝ๐—ฐ๐—ผ๐—บ๐—ถ๐—ป๐—ด ๐—ถ๐—ป๐—ถ๐˜๐—ถ๐—ฎ๐˜๐—ถ๐˜ƒ๐—ฒ๐˜€, ๐—–๐—ฎ๐—น๐—น-๐—ณ๐—ผ๐—ฟ-๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฎ๐—ป๐—ฑ ๐—›๐—ฒ๐—ฎ๐—น๐˜๐—ต๐—ซ ๐—œ๐—ป๐—ป๐—ผ๐˜ƒ๐—ฎ๐˜๐—ถ๐—ผ๐—ป ๐—ฆ๐—ฎ๐—ป๐—ฑ๐—ฏ๐—ผ๐˜…
Call-for-Innovation aims to turn aspirations into tangible value by experimenting with ideas alongside industry partners in an agile and iterative process. HealthX Innovation Sandbox enables public healthcare institutes and tech partners to conduct rapid experimentation and assessments to ensure the viability of innovative projects before full-scale implementation.
- ๐—–๐˜†๐—ฏ๐—ฒ๐—ฟ๐˜€๐—ฒ๐—ฐ๐˜‚๐—ฟ๐—ถ๐˜๐˜† ๐—Ÿ๐—ฎ๐—ฏ๐—ฒ๐—น๐—น๐—ถ๐—ป๐—ด ๐—ฆ๐—ฐ๐—ต๐—ฒ๐—บ๐—ฒ ๐—ณ๐—ผ๐—ฟ ๐— ๐—ฒ๐—ฑ๐—ถ๐—ฐ๐—ฎ๐—น ๐——๐—ฒ๐˜ƒ๐—ถ๐—ฐ๐—ฒ๐˜€ (๐—–๐—Ÿ๐—ฆ๐— ๐——)
The crucial step in preparing for the upcoming Health Information Bill by MOH. Notably, Level 1 CLS requirements align with HSA's standards, establishing stronger safeguards in securing health data.

Success stories from HealthTEC.SG-Singapore Health Technologies Consortium's accelerator offers valuable lessons on navigating the healthtech landscape. It is inspiring to see such strong collaboration between healthcare institutions, industry partners, and innovators to drive impactful changes.
ARQon is welcoming industry players to collaborate and be a part of the transformative future of healthcare๐Ÿค

2_edited_edited.jpg

What Italyโ€™s Evolving MDR Enforcement Means for Medical...

Our upcoming events are posted in
ATTOPOLIS
bottom of page